Conference item icon

Conference item

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo

Subtitle:
Conference abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1183/1393003.congress-2017.PA3971

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM; NDM Strategic
Subgroup:
NDM Experimental Medicine
Oxford college:
Lady Margaret Hall
Hargaden, B More by this author
Bradding, P More by this author
Wardlaw, AJ More by this author
Brightling, CE More by this author
Expand authors...
Publisher:
European Respiratory Society Publisher's website
Volume:
50
Issue:
S61
Pages:
Article: PA3971
Publication date:
2017-12-06
Acceptance date:
2017-05-20
DOI:
EISSN:
1399-3003
ISSN:
0903-1936
Pubs id:
pubs:871687
URN:
uri:feff2415-556a-4c3d-8232-a5f1cac24c9b
UUID:
uuid:feff2415-556a-4c3d-8232-a5f1cac24c9b
Local pid:
pubs:871687

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP